Part of Duke Health, the Duke Cancer Institute (DCI) is a unique entity that encompasses the wide range of groundbreaking cancer programs, projects and collaborations that result in cutting-edge research and world-class care for more than 8,000 new patients each year. Duke was designated as one of the National Cancer Institute’s 8 original comprehensive cancer centers in 1973; today, the Duke Cancer Institute continues to challenge boundaries and embrace innovation by providing specialized, multidisciplinary treatment for patients with every type of cancer.

Duke Health includes the Duke University School of Medicine, Duke-NUS Medical School, Duke University School of Nursing and Duke University Health System, and intersects with programs in the Duke Global Health Institute, as well as in schools and centers across Duke University. Duke Health is steeped in its commitment to improving the health and wellbeing of people across North Carolina and around the world by conducting the most innovative biomedical research; translating that research into new methods of prevention, diagnosis and treatment; educating the healthcare professionals of tomorrow; and developing better models of global and community health.